Hikma Suspends Roll-Out Of Advair Rival
Follows Amendment Filed With US FDA Over Packaging Update
Executive Summary
Hikma has temporarily stopped the roll-out of its rival to Advair Diskus in the US after it filed an amendment to its ANDA over packaging controls.